查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618287

生物分析檢驗服務市場評估:檢驗類型·分子·用途·終端用戶·各地區的機會及預測 (2018-2032年)

Bioanalytical Testing Services Market Assessment, By Test Type, By Molecule, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 234 Pages | 商品交期: 3-5個工作天內

價格

全球生物分析測試服務市場規模預計將從 2024 年的 40.4 億美元增長到 2032 年的 91 億美元，預測期內複合年增長率為 10.69%。

研發費用的增加、臨床試驗數量的增加以及對生物製劑和生物相似藥的需求正在促進生物分析測試服務的市場成長。這增加了對專業測試服務的需求並強化了外包趨勢。因此，技術進步預計將在未來幾年持續發展並創造強勁的市場成長環境。

糖尿病、癌症和心血管疾病等慢性疾病的增加加速了對生物分析測試服務的需求。據世界衛生組織稱，非傳染性疾病佔全球每年死亡人數的 74%。這種增加的負擔需要先進的藥物開發和精準醫學，其中生物分析測試至關重要。這些服務提供對治療功效和安全性的適當和準確的評估，有助於藥物創新和監管合規性，以滿足世界各地不斷增長的醫療保健需求。

CRO 也透過開設最先進的生物分析實驗室和戰略合作夥伴關係來擴大其全球影響力。這些活動增強了我們的服務範圍，簡化了藥物開發流程，並確保這些服務符合當地法規。這種集中擴張增加了對區域性和專業生物分析測試的需求，創造了新的成長機會。

本報告提供全球生物分析檢驗服務的市場調查，彙整市場定義和概要，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，產業結構，影響市場成長因素的分析，案例研究，競爭情形，主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球生物分析檢驗服務市場展望

  • 市場規模的分析·預測
  • 市場佔有率的分析·預測
    • 檢驗各類型
    • 各分子
    • 各用途
    • 各終端用戶
    • 各地區
    • 企業佔有率分析
  • 市場地圖分析

第5章 北美的生物分析檢驗服務市場展望

  • 市場規模的分析·預測
  • 市場佔有率的分析·預測
  • 各國市場評估
    • 美國
    • 加拿大
    • 墨西哥

第6章 歐洲的生物分析檢驗服務市場展望

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章 亞太地區的生物分析檢驗服務市場展望

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的生物分析檢驗服務市場展望

  • 巴西
  • 阿根廷

第9章 中東·非洲的生物分析檢驗服務市場展望

  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 以色列

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 大環境分析

第15章 價格分析

第16章 市場動態

  • 推動市場要素
  • 市場課題

第17章 市場趨勢·展開

第18章 法律規範和革新

  • 臨床試驗
  • 法規當局的認證

第19章 專利的形勢

第20章 案例研究

第21章 競爭情形

  • 前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大企業的形勢
    • WuXi AppTec Co., Ltd.
    • Eurofins Scientific SE
    • Charles River Laboratories International, Inc.
    • ICON Plc
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • SGS Societe Generale de Surveillance SA
    • Intertek Group plc
    • Frontage Laboratories, Inc.
    • BioAgilytix Labs, LLC

第22章 策略性建議

第23章 關於本公司·免責聲明

Product Code: MX12437

Global bioanalytical testing services market is projected to witness a CAGR of 10.69% during the forecast period 2025-2032, growing from USD 4.04 billion in 2024 to USD 9.10 billion in 2032. Growing R&D expenditure, rise in clinical trials, and demand for biologics and biosimilars augment the market's growth for bioanalytical testing services. This drives the demand for specialty testing services and enhances the trend of outsourcing; therefore, it improves technological advancement, which can collectively generate a strong market growth environment in the following years.

The rising cases of chronic diseases like diabetes, cancer, and cardiovascular disorders fuel the requirement for bioanalytical testing services. As per WHO, non-communicable diseases account for 74% of all global deaths annually. This increased burden demands a requirement for advanced drug development and precision medicine, wherein bioanalytical testing would be of immense importance. Such services provide proper and accurate therapeutic efficacy and safety assessment, thereby contributing to innovation in pharmaceuticals and regulatory compliance that satisfies increased healthcare demands around the globe.

Furthermore, CROs are expanding their global reach by opening state-of-the-art bioanalytical labs and strategic partnerships. These activities enhance the services offered, streamline drug development processes, and ensure that these services comply with regional regulations. This focused expansion unlocks new growth opportunities as the demand for localized and specialized bioanalytical testing increases. In August 2024, BioAgilytix Labs, LLC, recently opened the expanded 360biolabs laboratory in Melbourne, Australia. This cutting-edge facility provides a broad range of bioanalytical services such as LC-MS/MS, molecular testing, biomarker analysis, flow cytometry, large molecule PK and immunogenicity, virology, and central lab services, all performed in a quality-assured environment. This expansion supports global pharmaceutical and biotech clients, driving significant growth opportunities in the market.

Increasing R&D Expenditure Boosts Market Demand

Increasing R&D spending is also propelling the demand for bioanalytical testing in the market. As pharmaceutical companies invest more in R&D, clinical trials and drug development are rising, demanding more comprehensive bioanalytical testing services. Furthermore, pharmaceuticals' improvement and acceleration of R&D manufacturing units to enhance efficiency and make drug development more streamlined involves implementing advanced technologies and automation, for which specialized bioanalytical testing is required to ensure quality and safety. This concern about biologics and biosimilars also leads to more compatibility studies, stability testing, and protein analysis, further driving the bioanalytical testing market. In November 2024, AstraZeneca PLC made a USD 3.5 billion investment to accelerate R&D and manufacturing in the U.S. This expansion includes a new R&D center in Massachusetts and a next-gen biologics facility in Maryland. These improvements boost the development of leading-edge therapies and drive considerable growth opportunities in the market. With higher R&D investment comes greater demand for all-inclusive bioanalytical services for new pharmaceutical development and approval.

Rising Number of Clinical Trials Support Market Expansion

The rise in clinical trials has greatly propelled the growth of the bioanalytical testing services market. The volume of biological samples is increasing, and the complexity of the trials involving biologics and personalized medicines require advanced bioanalytical methods because of their tailored treatment approaches and complex molecular structures. Therefore, the demand for bioanalytical testing increases. Moreover, outsourcing bioanalytical testing, which focuses on biopharmaceuticals, including gene therapies and biosimilars, strengthens the market by improving efficiency and boosting investment in advanced technologies by pharmaceutical companies. Additionally, various collaborations ensure comprehensive clinical trial services in several companies to ease all drug development processes. All these collaborations positively influence the market through data accuracy, regulation compliance, and acceleration of new pharmaceutical approvals for its growth. In March 2024, EPNextS, Inc. and Frontage Laboratories, Inc. collaborated to improve early-phase clinical trials in Japan. This collaboration is meant to overcome the delay in drug availability due to strict regulations and complicated procedures. Combining their expertise, they are trying to streamline drug development and enhance market growth opportunities through improved access to innovative therapies.

Pharmaceuticals and Biopharmaceutical Companies Account for Significant Share of the Market

The pharmaceutical and biopharmaceutical firms are the most prominent end-users in this market for bioanalytical testing services, focusing on developing drugs and, hence, for severe stringent regulations. Such companies rely on bioanalytical testing for early-phase development, pharmacokinetics, and clinical laboratory testing. This has been one of the significant growth drivers for outsourcing such activities for cost savings and high-end expertise. Demand for personalized medicine and biologics is continuously growing and will continue to drive this trend. This trend further followed the increasing demand for personalized medicine and biologics.

Many biopharma and biotechnology companies have extended their partnership with CROs for bioanalytical services, which has accelerated biological drug development. This recent surge in outsourcing reflects the strategic shift to streamline operations and meets the rising demand for innovative therapies. For instance, in May 2024, BioAgilytix Labs, LLC, and BBI Solutions OEM Limited partnered to streamline bioanalytical testing. This partnership aligns reagent development with assay creation, making testing easier for pharma and biopharma sponsors. This streamlined approach accelerates the market entry of innovative therapies.

North America Holds Major Market Share

North America dominates the bioanalytical testing services market because of innovation and strong infrastructure. The region has well-established and developed facilities. In particular, the United States has many pharmaceutical and biotechnology companies, which creates a high demand for bioanalytical testing services. Also, strict FDA regulations in the region ensure that pharmaceutical companies maintain high-quality testing standards, which demand bioanalytical testing services. Thus, major companies are expanding their testing service portfolios to meet the increasing demand. In August 2024, SGS Societe Generale de Surveillance SA launched its new bioanalytical testing services in North America with the help of Agilex Biolabs Pty Ltd. This expansion provides more extensive, high-quality testing solutions and enhances market growth through comprehensive support for clinical trials and drug development.

Moreover, the growing need for advanced testing methods, such as immunoassays and electrophoresis, will further drive the market growth in the region. The region's strength is further emphasized due to its significant R&D investment and focus on new and innovative biopharmaceutical drug development, which enables it to set the pace of excellence in bioanalytical testing.

Future Market Scenario (2025-2032F)

The bioanalytical testing services market is anticipated to grow with the rise of R&D expenditure, biopharmaceutical industry expansion, technological advancements, severe regulatory compliance, and outsourcing trends that increase demand during the forecast period.

Strategic collaborations between pharmaceutical companies and CROs will expand the scope of high-end bioanalytical testing solutions to address varied pharmaceutical and biopharma requirements and present new growth opportunities. For example, in October 2024, Synexa Life Sciences BV enhanced its bio-analysis capabilities by acquiring Alderley Analytical Ltd. The acquisition strengthens Synexa's growth strategy and enhances its biomarker and bioanalytical assay capability, including DNA, RNA, protein, cell, and tissue analysis.

Additionally, key players are expanding their services to invest more in the advancements that support market expansion. In September 2024, Laboratory Corporation of America Holdings expanded its molecular bioanalytical laboratory in Indiana. The expansion enhanced LabCorp's global capacity to deliver advanced therapies more quickly to patients. Expanding bioanalytical capabilities supports biopharmaceutical companies, which drives future market growth and accelerates the availability of life-saving treatments.

Key Players Landscape and Outlook

Market players aim to grow by expanding services and adopting new technologies. They enter into strategic partnerships, mergers, and acquisitions to improve their offerings and benefit from the technology available to enhance their global market position.

In October 2024, Eurofins Scientific SE acquired clinical diagnostics operations for the German company SYNLAB International GmbH in Spain. The deal increases the company's commitment to delivering the best testing services worldwide. Eurofins Scientific SE considers itself the trusted, sophisticated partner of private and public sectors involved in health services, private hospitals, and insurance companies, ensuring excellent testing facilities.

In January 2024, Frontage Laboratories, Inc. expanded its European footprint by acquiring the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (part of an NMS Group S.p.A). The acquisition is one of the most significant steps forward for the company from its base in Italy, focusing on providing the best quality and cutting-edge services to clients.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bioanalytical Testing Services Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Test Type
      • 4.2.1.1. Pharmacokinetic Testing
      • 4.2.1.2. Pharmacodynamic Testing
      • 4.2.1.3. Biomarker Testing
      • 4.2.1.4. Virology Testing
      • 4.2.1.5. Serology testing
      • 4.2.1.6. Cell-based Assays
      • 4.2.1.7. Other Test Types
    • 4.2.2. By Molecule
      • 4.2.2.1. Small Molecule
      • 4.2.2.2. Large Molecule
    • 4.2.3. By Application
      • 4.2.3.1. Oncology
      • 4.2.3.2. Neurology
      • 4.2.3.3. Cardiology
      • 4.2.3.4. Infectious Diseases
      • 4.2.3.5. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Pharmaceutical and Biotechnology Companies
      • 4.2.4.2. Contract Research Organizations (CROs)
      • 4.2.4.3. Research & Academic Institutes
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Test Type
    • 4.3.2. By Molecule
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Bioanalytical Testing Services Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Test Type
      • 5.2.1.1. Pharmacokinetic Testing
      • 5.2.1.2. Pharmacodynamic Testing
      • 5.2.1.3. Biomarker Testing
      • 5.2.1.4. Virology Testing
      • 5.2.1.5. Serology testing
      • 5.2.1.6. Cell-based Assays
      • 5.2.1.7. Other Test Types
    • 5.2.2. By Molecule
      • 5.2.2.1. Small Molecule
      • 5.2.2.2. Large Molecule
    • 5.2.3. By Application
      • 5.2.3.1. Oncology
      • 5.2.3.2. Neurology
      • 5.2.3.3. Cardiology
      • 5.2.3.4. Infectious Diseases
      • 5.2.3.5. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceutical and Biotechnology Companies
      • 5.2.4.2. Contract Research Organizations (CROs)
      • 5.2.4.3. Research & Academic Institutes
      • 5.2.4.4. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Bioanalytical Testing Services Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Test Type
          • 5.3.1.2.1.1. Pharmacokinetic Testing
          • 5.3.1.2.1.2. Pharmacodynamic Testing
          • 5.3.1.2.1.3. Biomarker Testing
          • 5.3.1.2.1.4. Virology Testing
          • 5.3.1.2.1.5. Serology testing
          • 5.3.1.2.1.6. Cell-based Assays
          • 5.3.1.2.1.7. Other Test Types
        • 5.3.1.2.2. By Molecule
          • 5.3.1.2.2.1. Small Molecule
          • 5.3.1.2.2.2. Large Molecule
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Oncology
          • 5.3.1.2.3.2. Neurology
          • 5.3.1.2.3.3. Cardiology
          • 5.3.1.2.3.4. Infectious Diseases
          • 5.3.1.2.3.5. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Pharmaceutical and Biotechnology Companies
          • 5.3.1.2.4.2. Contract Research Organizations (CROs)
          • 5.3.1.2.4.3. Research & Academic Institutes
          • 5.3.1.2.4.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Bioanalytical Testing Services Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Bioanalytical Testing Services Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Bioanalytical Testing Services Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Bioanalytical Testing Services Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. WuXi AppTec Co., Ltd.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Eurofins Scientific SE
    • 21.3.3. Charles River Laboratories International, Inc.
    • 21.3.4. ICON Plc
    • 21.3.5. Thermo Fisher Scientific Inc.
    • 21.3.6. Laboratory Corporation of America Holdings
    • 21.3.7. SGS Societe Generale de Surveillance SA
    • 21.3.8. Intertek Group plc
    • 21.3.9. Frontage Laboratories, Inc.
    • 21.3.10. BioAgilytix Labs, LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 3. Global Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 4. Global Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Bioanalytical Testing Services Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 9. North America Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 10. North America Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 15. United States Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 16. United States Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 20. Canada Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 21. Canada Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 25. Mexico Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 26. Mexico Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 30. Europe Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 31. Europe Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 36. Germany Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 37. Germany Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 41. France Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 42. France Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 43. France Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 46. Italy Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 47. Italy Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 51. United Kingdom Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 52. United Kingdom Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 56. Russia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 57. Russia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 61. Netherlands Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 62. Netherlands Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 66. Spain Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 67. Spain Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 71. Turkey Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 72. Turkey Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 76. Poland Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 77. Poland Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 81. South America Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 82. South America Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 87. Brazil Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 88. Brazil Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 92. Argentina Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 93. Argentina Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 97. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 98. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 101. India Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 103. India Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 104. India Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 105. India Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 108. China Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 109. China Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 110. China Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 113. Japan Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 114. Japan Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 118. Australia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 119. Australia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 123. Vietnam Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 124. Vietnam Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 128. South Korea Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 129. South Korea Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 133. Indonesia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 134. Indonesia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 138. Philippines Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 139. Philippines Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 143. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 144. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 149. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 150. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 154. UAE Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 155. UAE Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
  • Figure 159. South Africa Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
  • Figure 160. South Africa Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Test Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Molecule Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024